Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade

Conclusion: These findings propose that curcumin may exercise its anti-cancer effects on gastric cancer cells, partly by suppressing the PI3K signaling pathway. This study's outcomes support curcumin's potential as a therapeutic agent for gastric cancer and encourage further exploration of its underlying molecular mechanisms and in vivo effectiveness.PMID:37933268 | PMC:PMC10625731 | DOI:10.1177/15593258231203585

Source: Dose Response - November 7, 2023 Category: Drugs & Pharmacology Authors: Gen Xi Qingtao Dong Bo Yang Desheng Jiao Shahanavaj Khan Source Type: research